GPCRs-Targeted Drug Discovery Summit Leaderboard
  • Wednesday, May 6, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Obesity & Weight Loss Drug Development Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 797

MedShape declares successful performance of first surgeries using DynaNail XL

Jan 31, 2018
Industry leader in orthopaedic devices using advanced functional materials, MedShape declared successful performance of first surgeries using DynaNail XL TTC Fusion System.  The…
Read More...

Mallinckrodt enrolls first patient in Phase 4 Trial of H.P Acthar Gel

Jan 31, 2018
Mallinckrodt plc affirmed enrolling first patient in the company's Phase 4, multi center, randomized, double-blind, placebo-controlled pilot study to facilitate evaluation of the…
Read More...

FDA clears Multi Radiance Medical’s MR4 laser technology for neck and Shoulder pain

Jan 31, 2018
U.S  Food and Drug Administration conceded to Multi  Radiance Medical's MR4 Laser technology for neck and shoulder pain relief under the Product Classification NHN. MR4 Laser technology…
Read More...

U.S FDA grants Fast Track designation to Takeda’s TAK-426

Jan 31, 2018
Takeda Pharmaceutical company Limited asserted that the U.S Food and Drug Administration has extended Fast Track designation to TAK-426 i.e Takeda's Zika virus vaccine candidate. …
Read More...

Foundation Medicine and EORTC collaborate for SPECTA

Jan 31, 2018
European Organisation for Research and Treatment of Cancer (EORTC) and Foundation Medicine collaborate to ascertain eligibility of patients for oncology clinical Trials of  Foundation…
Read More...

Puma Biotechnology and Medison Pharma partner to commercialize NERLYNX

Jan 31, 2018
In a bid to commercialize NERLYNX, Puma Biotechnology and Medison Pharma have forayed into an exclusive licensing agreement in Israel as it is currently not approved for…
Read More...

CEL-SCI patent for LEAPS Vaccine Platform Technology approved

Jan 31, 2018
U.S Patent and Trademark Office permits a patent titled  “Method for Inducing an Immune Response and Formulations Thereof” for CEL-SCI Corporation's LEAPS Vaccine Platform technology.…
Read More...

Agilent Technologies partners Science Exchange to advocate Agilent-enabled services

Jan 31, 2018
Agilent Technologies ventured into a partnership with Science Exchange to met out Agilent-enabled services to the research community worldwide. Carolina Livi, Ph.D., academic segment…
Read More...

Synteract appoints new Chief Commercial Officer, Jack Shannon

Jan 31, 2018
International contract research organization (CRO), Synteract paved way for a new Chief Commercial Officer on board, Jack Shannon. Jack Shannon joins Synteract from Chiltern where he…
Read More...

Sanofi to acquire Ablynx for €3.9 Billion

Jan 30, 2018
Sanofi and Ablynx engaged in the discovery and development of Nanobodies forayed into an agreement under which Sanofi will extend acquisition of all of the outstanding ordinary shares,…
Read More...
Previous 1 … 795 796 797 798 799 … 923 Next
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
GPCRs-Targeted Drug Discovery Summit
5th World ADC Summit South Korea
Extrahepatic Lipid-Based Nanoparticles Delivery Summit
World TPD & Induced Proximity Summit South Korea
Measuring Patient Engagement Summit
Investigative & Preclinical Toxicology Summit 2026
LEAP HR: Life Sciences West
Oligonucleotides for CNS Summit
R&D Procurement & Sourcing in Pharma Summit
In Vivo Cell Engineering & Gene Editing Summit
PFS & Injectable Drug Delivery West Coast
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
World Bispecific & T-Cell Engager Summit South Korea
TCR-Based Therapies Summit
PFS & Injectable Drug Devices East Coast
5th ADC Analytical Development Summit
Nasal Formulation & Delivery Summit
Peptide-Based Therapeutics Summit 2026
ALS Drug Development Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Gilead Completes $7.8 Billion Arcellx Acquisition Deal
  • EU Approves Rhapsido for Chronic Hives Treatment
  • Lilly to Acquire Ajax in $2.3 Billion Deal
  • Saphnelo Pen Approval Expands Lupus Treatment Access
  • BioMarin Completes $4.8 Billion Amicus Acquisition

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

Turning Biophysical Data into Confident Drug Discovery…

Targeted LNP Delivery Beyond the Liver: The Challenges…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.